Synpromics: AskBio Buys Synpromics

AskBio, a Research Triangle Park, N.C.-based clinical stage and gene therapy platform company, acquired Synpromics, an Edinburgh, United Kingdom-based developer of gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables precise cell targeting and gene expression. The amount of the deal was not disclosed. With the acquisition, AskBio expands its gene therapy [...]The post AskBio Buys Synpromics appeared first on FinSMEs.